GlassScriptPhysician profile
Jacquelyn C Wallander
NPI 1063180792
$991.48
in general payments reported to CMS, 2019-2025
9 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.03 · 2023: $388 · 2024: $390 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $124.77 | 2021-2024 | |
| Lilly USA, LLC | $124.71 | 2024 | Mounjaro |
| Corcept Therapeutics | $121.00 | 2024 | Korlym |
| Genentech USA, INC. | $120.68 | 2025 | Xolair |
| Vertos Medical, INC. | $117.21 | 2023 | Mild Device Kit |
| Alexion Pharmaceuticals, INC. | $112.43 | 2024 | Strensiq |
| Regeneron Healthcare Solutions, INC. | $94.50 | 2023 | Dupixent |
| Janssen Scientific Affairs, LLC | $92.85 | 2023 | Xarelto |
| Shield Therapeutics INC | $83.33 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Wallander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.